Business Description
Bonesupport Holding AB
ISIN : SE0009858152
Compare
Compare
Traded in other countries / regions
BONEX.Sweden0RQO.UKBOEUF.USA2B4.Germany IPO Date
2017-07-07Description
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and sells injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and has the ability to release pharmaceuticals to promote healing. Its products focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: North America (NA) and Europe & Rest of the World (EUROW).
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.22 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.14 | |||||
| Interest Coverage | 74.79 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 119.97 | |||||
| Beneish M-Score | -1.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 43.3 | |||||
| 3-Year FCF Growth Rate | 40.3 | |||||
| 3-Year Book Growth Rate | 10.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 36.02 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 46.21 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.98 | |||||
| 9-Day RSI | 51.16 | |||||
| 14-Day RSI | 52.01 | |||||
| 3-1 Month Momentum % | 10.97 | |||||
| 6-1 Month Momentum % | 28.91 | |||||
| 12-1 Month Momentum % | 94.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.74 | |||||
| Quick Ratio | 3.5 | |||||
| Cash Ratio | 1.42 | |||||
| Days Inventory | 610.71 | |||||
| Days Sales Outstanding | 64.59 | |||||
| Days Payable | 104.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.7 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 92.43 | |||||
| Operating Margin % | 12.64 | |||||
| Net Margin % | 11.12 | |||||
| FCF Margin % | -0.4 | |||||
| ROE % | 15.4 | |||||
| ROA % | 12.65 | |||||
| ROIC % | 17.77 | |||||
| 3-Year ROIIC % | 112.16 | |||||
| ROC (Joel Greenblatt) % | 51.59 | |||||
| ROCE % | 16.58 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 260 | |||||
| Forward PE Ratio | 81.27 | |||||
| PE Ratio without NRI | 260 | |||||
| PS Ratio | 28.79 | |||||
| PB Ratio | 35.16 | |||||
| Price-to-Tangible-Book | 35.93 | |||||
| Price-to-Operating-Cash-Flow | 4111.63 | |||||
| EV-to-EBIT | 233.34 | |||||
| EV-to-EBITDA | 210.95 | |||||
| EV-to-Revenue | 28.42 | |||||
| EV-to-FCF | -7499.07 | |||||
| Price-to-GF-Value | 1.38 | |||||
| Price-to-Graham-Number | 20.38 | |||||
| Price-to-Net-Current-Asset-Value | 58.94 | |||||
| Price-to-Net-Cash | 642.91 | |||||
| Earnings Yield (Greenblatt) % | 0.43 | |||||
| FCF Yield % | -0.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bonesupport Holding AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 72.13 | ||
| EPS (TTM) (€) | 0.12 | ||
| Beta | 0.55 | ||
| 3-Year Sharpe Ratio | 1.77 | ||
| 3-Year Sortino Ratio | 4.88 | ||
| Volatility % | 21.74 | ||
| 14-Day RSI | 52.01 | ||
| 14-Day ATR (€) | 0.986058 | ||
| 20-Day SMA (€) | 30.723 | ||
| 12-1 Month Momentum % | 94.08 | ||
| 52-Week Range (€) | 15.2 - 33 | ||
| Shares Outstanding (Mil) | 65.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bonesupport Holding AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bonesupport Holding AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bonesupport Holding AB Frequently Asked Questions
What is Bonesupport Holding AB(FRA:2B4)'s stock price today?
The current price of FRA:2B4 is €30.64. The 52 week high of FRA:2B4 is €33.00 and 52 week low is €15.20.
When is next earnings date of Bonesupport Holding AB(FRA:2B4)?
The next earnings date of Bonesupport Holding AB(FRA:2B4) is 2025-02-25.
Does Bonesupport Holding AB(FRA:2B4) pay dividends? If so, how much?
Bonesupport Holding AB(FRA:2B4) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers